These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31446426)

  • 1. Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy.
    Vijapurapu R; Geberhiwot T; Jovanovic A; Baig S; Nordin S; Kozor R; Leyva F; Kotecha D; Wheeldon N; Deegan P; Rusk RA; Moon JC; Hughes DA; Woolfson P; Steeds RP
    Heart; 2019 Dec; 105(23):1825-1831. PubMed ID: 31446426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy.
    Vijapurapu R; Bradlow W; Leyva F; Moon JC; Zegard A; Lewis N; Kotecha D; Jovanovic A; Hughes DA; Woolfson P; Steeds RP; Geberhiwot T
    Orphanet J Rare Dis; 2022 Jan; 17(1):6. PubMed ID: 34991670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy.
    Weidemann F; Maier SK; Störk S; Brunner T; Liu D; Hu K; Seydelmann N; Schneider A; Becher J; Canan-Kühl S; Blaschke D; Bijnens B; Ertl G; Wanner C; Nordbeck P
    Am J Cardiol; 2016 Jul; 118(2):264-74. PubMed ID: 27265676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Based Differences in Selected Cardiac Implantable Electronic Device Use: A 10-Year Statewide Patient Cohort.
    De Silva K; Nassar N; Badgery-Parker T; Kumar S; Taylor L; Kovoor P; Zaman S; Wilson A; Chow CK
    J Am Heart Assoc; 2022 Aug; 11(16):e025428. PubMed ID: 35943057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac device implantation in Fabry disease: A retrospective monocentric study.
    Sené T; Lidove O; Sebbah J; Darondel JM; Picard H; Aaron L; Fain O; Zenone T; Joly D; Charron P; Ziza JM
    Medicine (Baltimore); 2016 Oct; 95(40):e4996. PubMed ID: 27749559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, indications, risk factors, and survival of patients undergoing cardiac implantable electronic device implantation after open heart surgery.
    Wiggins NB; Chong DT; Houghtaling PL; Hussein AA; Saliba W; Sabik JF; Wazni O; Wilkoff BL; Tarakji KG
    Europace; 2017 Aug; 19(8):1335-1342. PubMed ID: 27738074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmias in Fabry cardiomyopathy.
    Acharya D; Robertson P; Kay GN; Jackson L; Warnock DG; Plumb VJ; Tallaj JA
    Clin Cardiol; 2012 Dec; 35(12):738-40. PubMed ID: 22886820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of cardiac implantable electronic device implantation in India: By Indian Society of Electrocardiology and Indian Heart Rhythm Society.
    Shenthar J; Bohra S; Jetley V; Vora A; Lokhandwala Y; Nabar A; Naik A; Calambur N; Gupta SB
    Indian Heart J; 2016; 68(1):68-71. PubMed ID: 26896270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice.
    Vijapurapu R; Kozor R; Hughes DA; Woolfson P; Jovanovic A; Deegan P; Rusk R; Figtree GA; Tchan M; Whalley D; Kotecha D; Leyva F; Moon J; Geberhiwot T; Steeds RP
    Trials; 2019 May; 20(1):314. PubMed ID: 31151481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.
    Teo WS; Kam R; Tan A
    Ann Acad Med Singap; 1998 Mar; 27(2):248-54. PubMed ID: 9663319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Implantable Electronic Devices: A Window Into the Evolution of Conduction Disease in Cardiac Amyloidosis.
    Rehorn MR; Loungani RS; Black-Maier E; Coniglio AC; Karra R; Pokorney SD; Khouri MG
    JACC Clin Electrophysiol; 2020 Sep; 6(9):1144-1154. PubMed ID: 32972550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Need for cardiac implantable electronic devices and long-term follow-up in recipients of orthotopic heart transplants.
    Gowani Z; Tomashitis B; Ospina MK; Waring A; Northup A; Ramu B; Van Bakel A; Gregoski M; Anderson J; Gold MR
    Heart Rhythm; 2024 Feb; 21(2):153-160. PubMed ID: 37879547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].
    Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D
    Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients.
    ; Shah MJ; Silka MJ; Silva JNA; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Bergen NHV; Wackel PL
    Heart Rhythm; 2021 Nov; 18(11):1888-1924. PubMed ID: 34363988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in cardiac implantable electronic device utilization in adults with congenital heart disease: a US nationwide analysis.
    Bhalla JS; Majmundar M; Patel KN; Deshmukh AJ; Connolly HM; Chirac A; Egbe AC; Miranda WR; Madhavan M
    J Interv Card Electrophysiol; 2024 Mar; 67(2):319-328. PubMed ID: 37392273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac implantable electronic devices in adults with tetralogy of Fallot.
    Egbe AC; Miranda WR; Madhavan M; Ammash NM; Missula VR; Al-Otaibi M; Fatola A; Kothapalli S; Connolly HM
    Heart; 2019 Apr; 105(7):538-544. PubMed ID: 30377259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
    Rizwan Sohail M; Henrikson CA; Jo Braid-Forbes M; Forbes KF; Lerner DJ
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):231-9. PubMed ID: 25243484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.